Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.
In the present randomized, controlled, double-blind trial (12 wk treatment plus double-blind extension for 12 wk), 25-50 mg/d agomelatine (n = 164) and 10-20 mg/d escitalopram (n = 160) were compared for short- and long-term efficacy, subjective sleep and tolerability. The effects of these drugs on...
Main Authors: | Corruble, E, de Bodinat, C, Belaïdi, C, Goodwin, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
AGOMELATINE VERSUS ESCITALOPRAM IN MAJOR DEPRESSIVE DISORDERS : A RANDOMIZED DOUBLE-BLIND, LONG TERM STUDY FOCUSING ON SLEEP SATISFACTION AND EMOTIONAL BLUNTING
by: Corruble, E, et al.
Published: (2011) -
Clinical studies on the efficacy of agomelatine on depressive symptoms.
by: Goodwin, G
Published: (2009) -
Antidepressant effect in older depressed patients: the lessons of two agomelatine trials
by: Goodwin, G, et al.
Published: (2017) -
Effects of escitalopram therapy on functional brain controllability in major depressive disorder
by: Fang, F, et al.
Published: (2022) -
Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
by: Goodwin, G, et al.
Published: (2009)